CIK 0001561921
- Non-accelerated filer
- Smaller reporting company
TELA Bio, Inc.
Sign in to watch- Ticker
- TELA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455320061
- Phone
- +1 484-320-2930
- Business address
- 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
- Open-market buys, last 90 days
- $167,238
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$167,238. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-24 | KOBLISH ANTONY Chief Executive Officer | Grant or award | +46,500 | 240,924 | ||
| 2022-02-24 | KOBLISH ANTONY Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +79,500 | 79,500 | ||
| 2022-02-24 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +5,572 | $11.74 | $65K | 3,299,499 |
| 2022-02-23 | Greenhalgh Ellis Skott Chief Technology Officer | Grant or award | +3,900 | 28,799 | ||
| 2022-02-23 | Greenhalgh Ellis Skott Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +6,675 | 6,675 | ||
| 2022-02-23 | Talmo Paul Chief Strategic Officer | Grant or award | +12,200 | 42,670 | ||
| 2022-02-23 | Talmo Paul Chief Strategic Officer | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | ||
| 2022-02-23 | Smeykal Megan Chief Accounting Officer | Grant or award | +5,000 | 12,717 | ||
| 2022-02-23 | Smeykal Megan Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +7,900 | 7,900 | ||
| 2022-02-23 | Cuca Roberto COO and CFO | Grant or award | +15,500 | 19,892 | ||
| 2022-02-23 | Cuca Roberto COO and CFO | Grant or award · Stock Option (Right to Buy) | +26,600 | 26,600 | ||
| 2022-02-23 | Murphy Peter C. Chief Commercial Officer | Grant or award | +10,800 | 24,298 | ||
| 2022-02-23 | Murphy Peter C. Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2022-02-23 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +750,657 | $11.75 | $8.8M | 3,293,927 |
| 2022-02-22 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +3,579 | $11.74 | $42K | 2,543,270 |
| 2022-02-18 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +2,520 | $11.75 | $30K | 2,539,691 |
| 2022-02-17 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +6,810 | $11.73 | $80K | 2,537,171 |
| 2022-02-16 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +10,000 | $11.72 | $117K | 2,530,361 |
| 2022-02-15 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +29 | $11.75 | $341 | 2,520,361 |
| 2022-02-14 | EW HEALTHCARE PARTNERS FUND 2, L.P. | Purchase | +10 | $11.75 | $118 | 2,520,332 |
Page 17 of 29 · 565 trades